It was previously reported that tau deletion does not change Aβ levels in young transgenic AD mice [18,19]; here we compared brain samples of old APP/PS1/tau-/- and APP/PS1/htau at 18 months to further study the influence of tau on Aβ production. This evidence concerns the gene MAPT and Alzheimer disease.